361 Capital’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

361 Capital’s Portfolio TVTY Stock Details TVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-36,449	Closed	-$1.45M	–	421
2018 Q1	$1.45M	Sell	36,449 -24,986	-41%	-$970K	0.36%	150
2017 Q4	$2.25M	Buy	+61,435	New	+$2.33M	0.56%	65

Other funds holding TVTY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

361 Capital's TVTY Position: Q2 2018 in Review

361 Capital sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2018, closing a stake of 36,449 shares — an estimated $1.45M sold.

361 Capital first reported a position in TVTY in Q4 2017 and held it in 2 quarters. The position peaked at $2.25M in Q4 2017. 210 funds tracked by Wall St. Rank hold TVTY as of Q2 2018.

361 Capital reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
361 Capital sold 36,449 Tivity Health, Inc. Common Stock shares in Q2 2018, an estimated $1.45M.
361 Capital first reported a position in Tivity Health, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
361 Capital's Tivity Health, Inc. Common Stock position peaked at $2.25M in Q4 2017.
210 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2018.

Based on 361 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.